FDA warns of increased risk of rare neurological syndrome associated with Janssen

FDA warns of increased risk of rare neurological syndrome associated with Janssen

By Excelsio Media on July 13, 2021 Also in covid-19, health

The Food and Drug Administration is warning of a possible increased risk of a rare neurological condition after getting the Johnson and Johnson COVID-19 vaccine. There are 100 suspected cases of Guillain-Barré syndrome out of the more than 12 million doses given.

Comments

Comentarios de Facebook

Subscribe to: Post Comments (Atom)